Nucleolin and ErbB2 inhibition reduces tumorigenicity of ErbB2-positive breast cancer
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2041-4889
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Nucleolin and ErbB2 inhibition reduces tumorigenicity of ErbB2-positive breast cancer ; volume:9 ; number:2 ; day:19 ; month:1 ; year:2018 ; pages:1-13 ; date:2.2018
Cell death & disease ; 9, Heft 2 (19.1.2018), 1-13, 2.2018
- Urheber
-
Wolfson, Eya
- Beteiligte Personen und Organisationen
-
Solomon, Shira
Schmukler, Eran
Goldshmit, Yona
Pinkas-Kramarski, Ronit
SpringerLink (Online service)
- DOI
-
10.1038/s41419-017-0067-7
- URN
-
urn:nbn:de:1111-201804119791
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
- 14.08.2025, 10:59 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Wolfson, Eya
- Solomon, Shira
- Schmukler, Eran
- Goldshmit, Yona
- Pinkas-Kramarski, Ronit
- SpringerLink (Online service)
Ähnliche Objekte (12)
Genetische Analyse des Tyrosinkinase-Rezeptors ErbB2
Genetische Analyse des Tyrosinkinase-Rezeptors ErbB2
LOXL2 induces aberrant acinar morphogenesis via ErbB2 signaling
Treatment of ErbB2 breast cancer by mitochondrial targeting
Nuclear ErbB2 expression in hepatocytes in liver disease
Coordinate transcriptional regulation of ErbB2/3 by C-terminal binding protein 2 signals sensitivity to ErbB2 inhibition in pancreatic adenocarcinoma
Focal adhesion kinase contributes to proliferative potential of ErbB2 mammary tumour cells but is dispensable for ErbB2 mammary tumour induction in vivo
ErbB2 signaling at the crossing between heart failure and cancer
Cholesterol content in cell membrane maintains surface levels of ErbB2 and confers a therapeutic vulnerability in ErbB2-positive breast cancer
Cyanidin-3-Glucoside inhibits ethanol-induced invasion of breast cancer cells overexpressing ErbB2
Lack of interaction between ErbB2 and insulin receptor substrate signaling in breast cancer
Detection of erbB2 copy number variations in plasma of patients with esophageal carcinoma
Genetische Analyse des Tyrosinkinase-Rezeptors ErbB2
Genetische Analyse des Tyrosinkinase-Rezeptors ErbB2
LOXL2 induces aberrant acinar morphogenesis via ErbB2 signaling
Treatment of ErbB2 breast cancer by mitochondrial targeting
Nuclear ErbB2 expression in hepatocytes in liver disease
Coordinate transcriptional regulation of ErbB2/3 by C-terminal binding protein 2 signals sensitivity to ErbB2 inhibition in pancreatic adenocarcinoma
Focal adhesion kinase contributes to proliferative potential of ErbB2 mammary tumour cells but is dispensable for ErbB2 mammary tumour induction in vivo
ErbB2 signaling at the crossing between heart failure and cancer
Cholesterol content in cell membrane maintains surface levels of ErbB2 and confers a therapeutic vulnerability in ErbB2-positive breast cancer
Cyanidin-3-Glucoside inhibits ethanol-induced invasion of breast cancer cells overexpressing ErbB2
Lack of interaction between ErbB2 and insulin receptor substrate signaling in breast cancer
Detection of erbB2 copy number variations in plasma of patients with esophageal carcinoma
Genetische Analyse des Tyrosinkinase-Rezeptors ErbB2
Genetische Analyse des Tyrosinkinase-Rezeptors ErbB2
LOXL2 induces aberrant acinar morphogenesis via ErbB2 signaling
Treatment of ErbB2 breast cancer by mitochondrial targeting
Nuclear ErbB2 expression in hepatocytes in liver disease
Coordinate transcriptional regulation of ErbB2/3 by C-terminal binding protein 2 signals sensitivity to ErbB2 inhibition in pancreatic adenocarcinoma
Focal adhesion kinase contributes to proliferative potential of ErbB2 mammary tumour cells but is dispensable for ErbB2 mammary tumour induction in vivo
ErbB2 signaling at the crossing between heart failure and cancer
Cholesterol content in cell membrane maintains surface levels of ErbB2 and confers a therapeutic vulnerability in ErbB2-positive breast cancer
Cyanidin-3-Glucoside inhibits ethanol-induced invasion of breast cancer cells overexpressing ErbB2
Lack of interaction between ErbB2 and insulin receptor substrate signaling in breast cancer